SEC 13F Intelligence

Ikarian Capital, LLC / CAPR

Ikarian Capital, LLC’s Capricor Therapeutics Inc Position

Does Ikarian Capital, LLC own Capricor Therapeutics Inc (CAPR)? Yes — 528.0K shares worth $16M (+1.30% of its 13F portfolio) as of Q1 2026, down from 578.0K shares the prior filed quarter.

Position Value
$16M
Q1 2026
Shares
528.0K
% of Portfolio
+1.30%
Quarters Held
4
currently held

Position History CAPR

Reported value by quarter
Q3 ’24: $5MQ3 ’24Q3 ’25: $2MQ3 ’25Q4 ’25: $17MQ4 ’25Q1 ’26: $16MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026528.0K$16M+1.30%
Q4 2025578.0K$17M+1.30%
Q3 2025264.6K$2M+0.19%
Q3 2024300.0K$5M+0.64%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ikarian Capital, LLC’s full portfolio or all institutional holders of CAPR.